Satori Neuro is a venture capital strategy of Satori Capital that invests in visionary companies pioneering breakthroughs in brain and mental health. Launched in 2023 and based in Dallas, Texas, it targets companies developing transformative treatments and disruptive business models addressing the world's most critical mental health and neurotechnology challenges.
Their most common stage is seed (57% of deals). Average disclosed round size is $16.9M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Seed
Last 12 Mo
0
Team
Randy Eisenman
Co-Founder and Managing Partner
James Haddaway
Satori Alpha Managing Partner & CIO / Satori Power Managing Partner
Jon Gard
Managing Director, Private Equity
Jeff Ekberg
Partner and Chief Financial Officer
Larry North
Operating Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Motif Neurotech | Series A | $18.8M | Jan 2024 |
 NextSense | Series A | $16M | Jan 2023 |
 tapouts | Seed | $3.2M | — |
 Holobiome | Seed | $9M | — |
| GGilgamesh Pharma | Series A | $60M | — |
 TARA Mind | Seed | $8M | — |
 Beckley Waves | Seed | $3.3M | — |
Top Co-Investors
Last updated: 20 October 2026